<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03934632</url>
  </required_header>
  <id_info>
    <org_study_id>180509/B/01</org_study_id>
    <nct_id>NCT03934632</nct_id>
  </id_info>
  <brief_title>The Impact of Leg Immobilization on Postabsorptive and Postprandial Muscle Protein Breakdown in Healthy Young Males</brief_title>
  <official_title>The Impact of Leg Immobilization on Postabsorptive and Postprandial Muscle Protein Breakdown in Healthy Young Males</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Exeter</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Exeter</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study will seek the quantify the simultaneous muscle protein synthesis and
      breakdown response with and without amino acid provision in humans following 2 days of
      immobilisation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle protein breakdown rate</measure>
    <time_frame>1 hour</time_frame>
    <description>Muscle protein breakdown rate (FBR, measured in %/h) during 1 hour of saline or amino acid infusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle protein breakdown rate</measure>
    <time_frame>3 hours</time_frame>
    <description>Muscle protein breakdown rate (FBR, measured in %/h) during 3 hours of saline or amino acid infusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle protein synthesis rate</measure>
    <time_frame>3 hours</time_frame>
    <description>Muscle protein synthesis rate (FSR, measured in %/h) during 3 hours of saline or amino acid infusion measured using a D5 phenylalanine infusion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Postabsorptive</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Saline infusion to mimic postabsorptive circulating amino acid concentrations</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Postprandial</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Amino acid infusion to mimic postprandial circulating amino acid concentrations</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Postabsorptive</intervention_name>
    <description>Saline will be infused to mimic postabsorptive circulating amino acid concentrations</description>
    <arm_group_label>Postabsorptive</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Postprandial</intervention_name>
    <description>An amino acid infusate will be administered to mimic postprandial circulating amino acid concentrations</description>
    <arm_group_label>Postprandial</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Immobilisation</intervention_name>
    <description>One leg will undergo 2 days immobilisation prior to the test day</description>
    <arm_group_label>Postabsorptive</arm_group_label>
    <arm_group_label>Postprandial</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male

          -  18-40 years of age

          -  Body mass index between 18.5 and 30

        Exclusion Criteria:

          -  Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes)

          -  Any diagnosed cardiovascular disease (e.g. deep vein thrombosis) or hypertension

          -  Chronic use of any prescribed or over the counter pharmaceuticals (that may modulate
             muscle protein metabolism)

          -  A personal or family history of epilepsy, seizures or schizophrenia

          -  Any known disorders in muscle metabolism

          -  Regular use of nutritional supplements

          -  Allergy to lidocaine

          -  Allergy to one or multiple amino acids

          -  Recent (within the last 6 months) or current musculoskeletal injury (e.g. leg
             fracture) as these could be exacerbated by the intervention e.g. unilateral leg
             immobilisation, or mean the participant is unable to use crutches.

          -  Having received or ingested a stable isotope tracer in the past
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marlou Dirks, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Exeter</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marlou Dirks, PhD</last_name>
    <phone>+44 (0)1392 725496</phone>
    <email>m.dirks@exeter.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Exeter</name>
      <address>
        <city>Exeter</city>
        <state>Devon</state>
        <zip>EX1 2LU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sport and Health Sciences</last_name>
      <phone>+44 (0)1392 725496</phone>
      <email>sshs-school-office@ex.ac.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>April 16, 2019</study_first_submitted>
  <study_first_submitted_qc>April 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 2, 2019</study_first_posted>
  <last_update_submitted>May 23, 2019</last_update_submitted>
  <last_update_submitted_qc>May 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

